FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental pharmacology, and concerns detecting and studying agents for increasing performance capability of laboratory animals in experiment. Method involves administration of actoprotector, represented by N-diphenylphosphoryl-N′-alkyl(C6-C10)urea with structural formula Ph2P(O)NHC(O)NHCH2CH=CH2 and gross-formula C16H17N2O2P. Compound is introduced in form of solution intragastrically through probe in dose of 10-15 mg/kg of animal's weight 20-40 minutes before the Porsolt test and test on a vertical screen-grid.
EFFECT: method provides higher performance level of laboratory animals in conditions of high physical activity, which can allow further use of said compound in medical and/or sports practice.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING N-DIPHENYLPHOSPHORYL-N′-ALKYL-(C-C)-UREAS | 2006 |
|
RU2296768C1 |
METHOD OF WORK EFFICIENCY LEVEL INCREASE FOR LABORATORY ANIMALS IN EXPERIMENT | 2007 |
|
RU2371175C2 |
METHOD FOR ENHANCING LEVEL OF WORK CAPACITY OF LABORATORY ANIMALS IN EXPERIMENT | 2006 |
|
RU2335021C2 |
MEDICATION STIMULATING PHYSICAL ENDURANCE | 2010 |
|
RU2451508C2 |
METHOD FOR ENHANCING LEVEL OF WORK CAPACITY OF LABORATORY ANIMALS IN EXPERIMENT | 2016 |
|
RU2634373C1 |
PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
METHOD OF CORRECTING DISORDERS OF IMMUNE AND PSYCHOEMOTIONAL STATUS OF ORGANISM IN EXPERIMENTAL INFORMATION STRESS | 2010 |
|
RU2432949C1 |
QUATERNARY AMMONIUM SALTS OF DIAZAADAMANTANS WITH ACTOPROTECTIVE ACTIVITY | 2021 |
|
RU2760459C1 |
METHOD OF TESTING PREPARATIONS WITH POTENTIAL PSYCOTROPIC OR ACT-PROTECTIVE ACTION | 2015 |
|
RU2601376C1 |
DRUG POSSESSING ACTOPROTECTIVE, ANTIHYPOXIC, NEUROPROTECTIVE, ANTIAMNESTIC AND THERMOPROTECTIVE ACTIVITY | 2011 |
|
RU2460529C1 |
Authors
Dates
2016-11-10—Published
2015-09-09—Filed